We've found
4,191
archived clinical trials in
Constipation
We've found
4,191
archived clinical trials in
Constipation
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Updated: 1/5/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Updated: 1/5/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Updated: 1/13/2016
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated: 1/13/2016
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Updated: 1/13/2016
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated: 1/13/2016
Click here to add this to my saved trials
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Updated: 1/13/2016
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated: 1/13/2016
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Updated: 1/13/2016
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated: 1/13/2016
Click here to add this to my saved trials
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Updated: 1/13/2016
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated: 1/13/2016
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Updated: 1/13/2016
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated: 1/13/2016
Click here to add this to my saved trials
Functional Magnetic Stimulation Enhances Gastrointestinal Motility in Patients With Chronic Constipation
Updated: 2/2/2016
A Prospective Trial to Study Whether Functional Magnetic Stimulation Enhances Gastrointestinal Motility in Patients With Chronic Constipation
Status: Enrolling
Updated: 2/2/2016
Functional Magnetic Stimulation Enhances Gastrointestinal Motility in Patients With Chronic Constipation
Updated: 2/2/2016
A Prospective Trial to Study Whether Functional Magnetic Stimulation Enhances Gastrointestinal Motility in Patients With Chronic Constipation
Status: Enrolling
Updated: 2/2/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Updated: 2/11/2016
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials